Klockgether T. Ataxias: diagnostic procedure and treatment. Nervenarzt. 2005;76:1275–85.

Article  CAS  PubMed  Google Scholar 

Schmahmann JD, Caplan D. Cognition, emotion and the cerebellum. Brain. 2006;129(2):290–2.

Article  PubMed  Google Scholar 

Manto M, Bower JM, Conforto AB, Delgado-García JM, Da Guarda SNF, Gerwig M, et al. Consensus paper: roles of the cerebellum in motor control—the diversity of ideas on cerebellar involvement in movement. Cerebellum. 2012;11:457–87.

Article  PubMed  PubMed Central  Google Scholar 

Joubert B, Gobert F, Thomas L, Saint-Martin M, Desestret V, Convers P, et al. Autoimmune episodic ataxia in patients with anti-CASPR2 antibody-associated encephalitis. Neurol Neuroimmunol Neuroinflammation. 2017;4(4):e371.

Article  Google Scholar 

Do LD, Gupton SL, Tanji K, Bastien J, Brugière S, Couté Y, et al. TRIM9 and TRIM67 are new targets in paraneoplastic cerebellar degeneration. Cerebellum. 2019;18(2):245–54.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jarius S, Wildemann B. Medusa head ataxia’: the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 2: Anti-PKC-gamma, anti-GluR-delta2, anti-Ca/ARHGAP26 and anti-VGCC. J Neuroinflammation. 2015;12:1–21.

Google Scholar 

Jarius S, Wildemann B. Medusa-head ataxia: the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 1: Anti-mGluR1, anti-homer-3, anti-Sj/ITPR1 and anti-CARP VIII. J Neuroinflammation. 2015;12:166.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jarius S, Wildemann B. Medusa head ataxia’: the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 3: anti-Yo/CDR2, anti-Nb/AP3B2, PCA-2, anti-Tr/DNER, other antibodies, diagnostic pitfalls, summary and outlook. J Neuroinflammation. 2015;12:1–22.

Google Scholar 

Xu X, Ren H, Li L, Wang J, Fechner K, Guan H. Anti-homer-3 antibody associated cerebellar ataxia: a rare case report and literature review. J Neuroimmunol. 2019;330:155–8.

Article  CAS  PubMed  Google Scholar 

Greene M, Lai Y, Baella N, Dalmau J, Lancaster E. Antibodies to delta/notch-like epidermal growth factor–related receptor in patients with anti-tr, paraneoplastic cerebellar degeneration, and Hodgkin lymphoma. JAMA Neurol. 2014;71(8):1003–8.

Article  PubMed  PubMed Central  Google Scholar 

Campana IG, Silva GD. Anti-Tr/DNER antibody–Associated Cerebellar Ataxia: a systematic review. Cerebellum. 2022;1–7.

Honnorat J, Antoine J-C. Paraneoplastic neurological syndromes. Orphanet J Rare Dis. 2007;2(1):1–8.

Article  Google Scholar 

Leypoldt F, Wandinger K-P. Paraneoplastic neurological syndromes. Clin Exp Immunol. 2014;175(3):336–48.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Christensen PB, Gregersen H, Almasi C. Anti-Tr/DNER antibody paraneoplastic cerebellar degeneration preceding a very late relapse of Hodgkin Lymphoma after 12 years. Cerebellum Ataxias. 2021;8(1):14.

Article  PubMed  PubMed Central  Google Scholar 

Dalmau J, Rosenfeld MR. Paraneoplastic syndromes of the CNS. Lancet Neurol. 2008;7(4):327–40.

Article  PubMed  PubMed Central  Google Scholar 

Zhang W, Ren H, Ren X, Fang F, Guan H. Autoimmune cerebellar ataxia associated with anti-purkinje cells antibodies: the next frontier of neuroimmunology. Ann Transl Med. 2023;11(7):285.

Article  CAS  PubMed  Google Scholar 

de Graaff E, Maat P, Hulsenboom E, van den Berg R, van den Bent M, Demmers J, et al. Identification of delta/notch-like epidermal growth factor‐related receptor as the tr antigen in paraneoplastic cerebellar degeneration. Ann Neurol. 2012;71(6):815–24.

Article  PubMed  Google Scholar 

Kemp KC, Cook AJ, Redondo J, Kurian KM, Scolding NJ, Wilkins A. Purkinje cell injury, structural plasticity and fusion in patients with Friedreich’s ataxia. Acta Neuropathol Commun. 2016;4(1):1–15.

Google Scholar 

Bernal F, Shams’Ili S, Rojas I, Sanchez-Valle R, Saiz A, Dalmau J, et al. Anti-tr antibodies as markers of paraneoplastic cerebellar degeneration and Hodgkin’s disease. Neurology. 2003;60(2):230–4.

Article  CAS  PubMed  Google Scholar 

Cai Y, Liu J, Ren H, Shi F, Che J, Geng Q, et al. Anti-Tr/DNER antibody-associated cerebellar ataxia: three rare cases report and literature review. Neurol Sci off J Ital Neurol Soc Ital Soc Clin Neurophysiol. 2023;44(1):397–403.

Google Scholar 

Ducray F, Demarquay G, Graus F, Decullier E, Antoine J, Giometto B, et al. Seronegative paraneoplastic cerebellar degeneration: the PNS E uronetwork experience. Eur J Neurol. 2014;21(5):731–5.

Article  CAS  PubMed  Google Scholar 

Greenlee JE, Brashear HR. Antibodies to cerebellar Purkinje cells in patients with paraneoplastic cerebellar degeneration and ovarian carcinoma. Ann Neurol off J Am Neurol Assoc Child Neurol Soc. 1983;14(6):609–13.

CAS  Google Scholar 

Eiraku M, Tohgo A, Ono K, Kaneko M, Fujishima K, Hirano T, et al. DNER acts as a neuron-specific notch ligand during Bergmann glial development. Nat Neurosci. 2005;8(7):873–80.

Article  CAS  PubMed  Google Scholar 

Chillakuri CR, Sheppard D, Lea SM, Handford PA. Notch receptor-ligand binding and activation: insights from molecular studies. Semin Cell Dev Biol. 2012;23(4):421–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kopan R, Ilagan MXG. The canonical notch signaling pathway: unfolding the activation mechanism. Cell. 2009;137(2):216–33.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Saito S-Y, Takeshima H. DNER as key molecule for cerebellar maturation. Cerebellum. 2006;5(3):227–31.

Article  CAS  PubMed  Google Scholar 

Tohgo A, Eiraku M, Miyazaki T, Miura E, Kawaguchi S-Y, Nishi M, et al. Impaired cerebellar functions in mutant mice lacking DNER. Mol Cell Neurosci. 2006;31(2):326–33.

Article  CAS  PubMed  Google Scholar 

Yamada K, Watanabe M. Cytodifferentiation of Bergmann glia and its relationship with Purkinje cells. Anat Sci Int. 2002;77(2):94–108.

Article  PubMed  Google Scholar 

Graus F, Ariño H, Dalmau J. Paraneoplastic neurological syndromes in Hodgkin and non-hodgkin lymphomas. Blood. 2014;123(21):3230–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Choi K-D, Kim JS, Park S-H, Kim YK, Kim SE, Smitt PS. Cerebellar hypermetabolism in paraneoplastic cerebellar degeneration. J Neurol Neurosurg Psychiatry. 2006;77(4):525–8.

Article  PubMed  PubMed Central  Google Scholar 

Tombak A, Uçar MA, Akdeniz A, Yilmaz A, Kaleagası H, Sungur MA, et al. Therapeutic plasma exchange in patients with neurologic disorders: review of 63 cases. Indian J Hematol Blood Transfus off J Indian Soc Hematol Blood Transfus. 2017;33(1):97–105.

Article  Google Scholar 

Sorgun MH, Erdogan S, Bay M, Ayyıldız E, Yücemen N, Iihan O, et al. Therapeutic plasma exchange in treatment of neuroimmunologic disorders: review of 92 cases. Transfus Apher Sci off J World Apher Assoc off J Eur Soc Haemapheresis. 2013;49(2):174–80.

Google Scholar 

Greenlee JE. Treatment of paraneoplastic cerebellar degeneration. Curr Treat Options Neurol. 2013;15(2):185–200.

Article  PubMed  PubMed Central  Google Scholar 

Perez EE, Orange JS, Bonilla F, Chinen J, Chinn IK, Dorsey M, et al. Update on the use of immunoglobulin in human disease: a review of evidence. J Allergy Clin Immunol. 2017;139(3):S1–46.

Article  CAS  PubMed  Google Scholar 

Gelfand EW. Intravenous immune globulin in autoimmune and inflammatory diseases. N Engl J Med. 2012;367(21):2015–25.